MLchartDataset catalogue

Alunbrig

Term · Oncology and biomedicine · MLC-T-ONC-000424

A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Alunbrig blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Alunbrig is a type of tyrosine kinase inhibitor. Also called brigatinib.

Table 1. Record
IdentifierMLC-T-ONC-000424
FieldOncology and biomedicine
Synonymsbrigatinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000424",
  "term": "Alunbrig",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Alunbrig blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Alunbrig is a type of tyrosine kinase inhibitor. Also called brigatinib.",
  "synonyms": [
    "brigatinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/alunbrig/"
}

Record 916 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.